Abnormal glucose tolerance contributes to the progression of chronic heart failure in patients with dilated cardiomyopathy

Hypertension Research

Volumn 29, Issue 10, 2006, Pages 775-782

  Kim, Jiyoong ^a   Nakatani, Satoshi ^a   Hashimura, Kazuhiko ^a   Komamura, Kazuo ^a   Kanzaki, Hideaki ^a   Asakura, Masanori ^a   Asanuma, Hiroshi ^a   Kokubo, Yoshihiro ^a   Tomoike, Hitonobu ^a   Kitakaze, Masafumi ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Diabetes mellitus; Heart failure; Impaired glucose tolerance; Voglibose

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CHOLESTEROL; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; STEROID; TRIACYLGLYCEROL; URIC ACID; VOGLIBOSE;

ADULT; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE METABOLISM; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE SIZE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY; PREVALENCE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT OUTCOME;

CARDIOMYOPATHY, DILATED; CHRONIC DISEASE; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEART FAILURE, CONGESTIVE; HUMANS; HYPOGLYCEMIC AGENTS; INOSITOL; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREVALENCE; SEVERITY OF ILLNESS INDEX;

EID: 33751581159     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.29.775     Document Type: Article

References (36)

1. Braunwald E, Bristow MR: Congestive heart failure: fifty years of progress. Circulation 2000; 102: 14-23.
2. Torre-Amione G: The syndrome of heart failure: emerging concepts in the understanding of its pathogenesis and treatment. Curr Opin Cardiol 1999; 14: 193-195.
3. Packer M: Neurohormonal interactions and adaptations in congestive heart failure. Circulation 1988; 77: 721-730.
4. Drexler H, Hornig B: Importance of endothelial function in chronic heart failure. J Cardiovasc Pharmacol 1996; 27: S9-S12.
5. Levine TB, Francis GS, Goldsmith SR, et al: Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma homione levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 1982; 49: 885-891.
6. Marangou AG, Alford FP, Ward G, et al: Hormonal effects of norepinephrine on acute glucose disposal in humans: a minimal model analysis. Metabolism 1988; 37: 885-891.
7. Juan CC, Chien Y, Wu LY, et al: Angiotensin II enhances insulin sensitivity in vitro and in vivo. Endocrinology 2005; 146: 2246-2254.
8. Risso A, Mercuri F, Quagliaro L, et al: Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol 2001; 281: E924-E930.
9. Quagliaro L, Piconi L, Assaloni R, et al: Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 2003; 52: 2795-2804.
10. Baumgartner-Parzer SM, Wagner L, Pettermann M, et al: High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes 1995; 44: 1323-1327.
11. Neri S, Signorelli SS, Torrisi B, et al: Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls. Clin Ther 2005; 27: 1764-1773.
12. Mykkanen L, Kuusisto J, Pyorala K, et al: Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 1993; 36: 553-559.
13. Swan JW, Walton C, Godsland IF, et al: Insulin resistance in chronic heart failure. Eur Heart J 1994; 15: 1528-1532.
14. Swan JW, Anker SD, Walton C, et al: Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol 1997; 30: 527-532.
15. Tenenbaum A, Motro M, Fisman EZ, et al: Functional class in patients with heart failure is associated with the development of diabetes. Am J Med 2003; 114: 271-275.
16. Wisniacki N, Taylor W, Lye M, Wilding JP: Insulin resistance and inflammatory activation in older patients with systolic and diastolic heart failure. Heart 2005; 91: 32-37.
17. Nielson C, Lange T: Blood glucose and heart failure in non-diabetic patients. Diabetes Care 2005; 28: 607-611.
18. He J, Ogden LG, Bazzano LA, et al: Risk factors for congestive heart failure in US men and women: NHANESI epidemiologic follow-up study. Arch Intern Med 2001; 161: 996-1002.
19. Shehadeh A, Regan TJ: Cardiac consequences of diabetes mellitus. Clin Cardiol 1995; 18: 301-305.
20. Kostis JB, Sanders M: The association of heart failure with insulin resistance and the development of type 2 diabetes. Am J Hypertens 2005; 18: 731-737.
21. Amato L, Paolisso G, Cacciatore F, et al, The Osservatorio Geriatrico Regione Campania Group: Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. Diabetes Metab 1997; 23: 213-218.
22. Norhammar A, Malmberg K: Heart failure and glucose abnormalities: an increasing combination with poor functional capacity and outcome. Eur Heart J 2000; 21: 1293-1294.
23. American Diabetes Association: Report of the expert committees on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 29: 1183-1197.
24. The DECODE Study Group on behalf of the European Diabetes Epidemiology Group: Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 1999; 354: 617-621.
25. Steel RGD, Torrie JH: Principles and Procedures of Statistics. A Biomedical Approach, 2nd ed. New York, McGraw-Hill Publishing Co, 1980, pp 137-238.
26. Tenenbaum A, Fisman EZ, Boyko V, et at: Hypertension in diet versus pharmacologically treated diabetics: mortality over a 5-year follow-up. Hypertension 1999; 33: 1002-1007.
27. Balkau B, Shipley M, Jarrett RJ, et al: High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 1998; 21: 360-367.
28. Fisman EZ, Motro M, Tenenbaum A, et al: Impaired fasting glucose concentrations in nondiabetic patients with ischemic heart disease: a marker for a worse prognosis. Am Heart J 2001; 141: 485-490.
29. Lillioja S, Mott DM, Spraul M, et al: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 1993; 329: 1988-1992.
30. Helmrich SP, Ragland DR, Leung RW, et al: Physical activity and reduced occurrence of non-insulin dependent diabetes mellitus. N Engl J Med 1991; 325: 147-152.
31. Murray AJ, Anderson RE, Watson GC, et al: Uncoupling proteins in human heart. Lancet 2004; 364: 1786-1788.
32. Wang XP, Zhang R, Wu K, et al: Angiotensin II mediates acinar cell apoptosis during the development of rat pancreatic fibrosis by AT1R. Pancreas 2004; 29: 264-270.
33. Scognamiglio R, Negut C, De Kreutzenberg SV, et al: Post-prandial myocardial perfusion in healthy subjects and in type 2 diabetic patients. Circulation 2005; 112: 179-184.
34. Minamino T, Kitakaze M: Investigation of cellular mechanisms for the treatment of chronic heart failure: insight to nitric oxide- and adenosine-dependent pathways. Expert Opin Invest Drugs 2002; 7: 99-110.
35. Sanada S, Node Y, Asanuma H, et al: Opening of ATP-sensitive potassium channel attenuates cardiac remodeling induced by chronic inhibition of nitric oxide synthesis - role of 70 kDa S6 kinase and extracellular signal-regulated kinase -. J Am Coll Cardiol 2002; 40: 991-997.
36. Hirooka Y, Eshima K, Setoguchi S, Kishi T, Egashira K, Takeshita A: Vitamin C improves attenuated angiotensin II-induced endothelium-dependent vasodilation in human forearm vessels. Hypertens Res 2003; 26: 953-959.